Is the dosing the same for atopic dermatitis patients aged 12+ years with uncontrolled moderate‑to‑severe hand and/or foot involvement?

All DUPIXENT-treated patients in AD-HAFT received DUPIXENT monotherapy for their hand and/or foot involvement.¹

Dosing for DUPIXENT in this study was consistent with the approved dosage in the Prescribing Information.¹